LPCN 0.33 up 23% ...data readout from their postpartum depression trial expected during this quarter followed by results from the liver cirrhosis trial
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.